Author Information
Jordi Carratalà is a prominent researcher in the field of Infectious Diseases, affiliated with the Infectious Diseases Department at Bellvitge University Hospital and IDIBELL, University of Barcelona, Spain. Additionally, he is associated with the Spanish Network for Research in Infectious Disease (REIPI), under the Instituto de Salud Carlos III in Madrid, Spain. His extensive work in infectious diseases, especially regarding bacterial infections and COVID-19, is well-recognized in the scientific community.Research Contributions
Jordi Carratalà has made significant contributions to the field of infectious diseases, particularly focusing on bacterial infections and the impact of antibiotic therapies. His research works address critical issues such as the efficacy of combination antibiotic therapies in neutropenic cancer patients, the management of bloodstream infections, and the challenges posed by resistant bacteria like Pseudomonas aeruginosa and Enterobacterales. He has also contributed to the understanding of COVID-19, examining the efficacy of treatments like Tocilizumab and the impact of the pandemic on infection control practices. His studies often employ systematic reviews, meta-analysis, and matched control studies to derive meaningful insights into treatment effectiveness and patient outcomes.Aliases
Jordi Carratalà is known by several aliases in the academic community, including J. Carratalà, Jordi Carratalà, J. Carratala, J Carratalá, J Carratala, and J A Carratalà. These variations are commonly used in scientific publications and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
435 |
| Total Citations |
15333 |
| H-index |
71 |
